Search Results 11-20 of 990 for Capsule

1. A Phase I, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Minnelide™ Capsules in Patients With Advanced Solid Tumors - Mayo Clinic

   A Phase I, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Minnelide™ Capsules in Patients With Advanced Solid Tumors - Mayo Clinic Overview Tab Title Description Study type Intervention...

2. Cataract surgery: Will my vision deteriorate after cataract surgery? - Mayo Clinic

   An eye doctor can use a laser to make an opening in the center of the cloudy lens capsule.

3. Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease - Mayo Clinic

   Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease - Mayo Clinic Overview Tab Title D...

4. Mayo Clinic enrolls first patient in phase 1 study of orally delivered capsule to treat recurrent Clostridium difficile infection – Mayo Clinic News Network

   The capsule is formulated to rehabilitate the human gut microbiome delivering a broad spectrum of live microbes into the patient's intestinal tract.

5. New option for massive irreparable rotator cuff tears - Mayo Clinic

   "The maximum thickness of commercially available dermal allografts is about 3.5 mm — half that of the autografts used in the original SCR technique and below the thickness of the native capsule," Dr.

6. Open-Label Safety Study of ADS-5102 in PD Patients With LID - Mayo Clinic

   Study IDs Site IRB Scottsdale/Phoenix, Arizona: 14-006225 NCT ID: NCT02202551 Sponsor Protocol Number: ADS-AMT-PD302 About this study This is a 52-week open-label study to evaluate the safety and tolerability of ADS-5102 oral capsules...

7. A Study of the Safety and Effectiveness of ADS-5102 in Patients with Multiple Sclerosis and a Walking Impairment - Mayo Clinic

   Study IDs Site IRB Rochester, Minnesota: 15-003326 NCT ID: NCT02471222 Sponsor Protocol Number: ADS-AMT-MS201 About this study This is a multi-center, randomized, double-blind, placebo-controlled, 2-arm, parallel group study of ADS-5102 extended rele...

8. ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study) - Mayo Clinic

   Study IDs Site IRB Scottsdale/Phoenix, Arizona: 14-006224 NCT ID: NCT02136914 Sponsor Protocol Number: ADS-AMT-PD301 About this study This is a multi-center, randomized, double-blind, placebo-controlled, 2-arm, parallel group study to evaluate the ef...

9. A Study of the Safety and Drug/Body Interactions of LAM-002A for Patients with Non-Hodgkin's Lymphoma - Mayo Clinic

   A Study of the Safety and Drug/Body Interactions of LAM-002A for Patients with Non-Hodgkin's Lymphoma - Mayo Clinic Overview Tab Title Description Study type Interventional Study phase I Study IDs Study type Interventional Describes the nature of a c...

10. Levodopa (Inhalation Route) Proper Use - Mayo Clinic

    Load 1 capsule into the capsule chamber of the inhaler.